28 Mar 2025 //
PRESS RELEASE
10 Feb 2025 //
PR NEWSWIRE
07 Feb 2025 //
PR NEWSWIRE
14 Jan 2025 //
PR NEWSWIRE
26 Dec 2024 //
PRNEWSWIRE
16 Dec 2024 //
PR NEWSWIRE
11 Sep 2024 //
PR NEWSWIRE
25 Jul 2024 //
PR NEWSWIRE
03 Jun 2024 //
PR NEWSWIRE
02 Jun 2024 //
PR NEWSWIRE
28 May 2024 //
PR NEWSWIRE
25 Mar 2024 //
PR NEWSWIRE
18 Mar 2024 //
PR NEWSWIRE
01 Feb 2024 //
PR NEWSWIRE
07 Dec 2023 //
PR NEWSWIRE
08 Oct 2023 //
PRESS RELEASE
08 Oct 2023 //
PR NEWSWIRE
19 Jun 2023 //
PHARMACEUTICAL TECHNOLOGY
16 Jun 2023 //
BUSINESSWIRE
14 Apr 2023 //
BUSINESSWIRE
13 Mar 2023 //
BUSINESSWIRE
08 Mar 2023 //
BUSINESSWIRE
06 Mar 2023 //
BUSINESSWIRE
16 Jan 2023 //
BUSINESSWIRE
02 Dec 2022 //
BUSINESSWIRE
02 Dec 2022 //
BUSINESSWIRE
01 Nov 2022 //
BUSINESSWIRE
14 Oct 2022 //
BUSINESSWIRE
11 Oct 2022 //
BUSINESSWIRE
27 Sep 2022 //
BUSINESSWIRE
02 Aug 2022 //
BUSINESSWIRE
13 Jul 2022 //
BUSINESSWIRE
03 Jun 2022 //
GLOBENEWSWIRE
10 May 2022 //
CLINICALTRIALSARENA
09 May 2022 //
BUSINESSWIRE
30 Mar 2022 //
BUSINESSWIRE
25 Jan 2022 //
PHARMABIZ
30 Dec 2021 //
CLINICALTRIALSARENA
29 Dec 2021 //
BUSINESSWIRE
27 Oct 2021 //
FIERCEPHARMA
15 Oct 2021 //
BUSINESSWIRE
08 Oct 2021 //
PRESS RELEASE
09 Sep 2021 //
PHARMABIZ
08 Sep 2021 //
BIOSPACE
27 Aug 2021 //
BUSINESSWIRE
11 Aug 2021 //
PHARMABIZ
15 Jul 2021 //
BUSINESS WIRE
08 Jun 2021 //
BUSINESSWIRE
28 Jan 2021 //
BIOSIMILARDEVELOPMENT
21 Jan 2021 //
BUSINESSWIRE
21 Jan 2021 //
BUSINESSWIRE
17 Dec 2020 //
BIOSIMILARDEVELOPMENT
17 Dec 2020 //
BIOSIMILARDEVELOPMENT
25 Nov 2020 //
BUSINESSWIRE
25 Nov 2020 //
BUSINESSWIRE
03 Sep 2020 //
BUSINESSWIRE
24 Aug 2020 //
BUSINESSWIRE
17 Jul 2020 //
BUSINESSWIRE
22 Jun 2020 //
BUSINESSWIRE